Dysregulation of Mesenchymal Cell Survival Pathways in Severe Fibrotic Lung Disease: The Effect of Nintedanib Therapy

by Rajesh K. Kasam, Rajesh K. Kasam, Rajesh K. Kasam, Geereddy B. Reddy, Anil G. Jegga, Anil G. Jegga, Satish K. Madala, Satish K. Madala
Published 2019-05-01

The Protective Effects of IL-31RA Deficiency During Bleomycin-Induced Pulmonary Fibrosis

by Dan J. K. Yombo, Dan J. K. Yombo, Varshini Odayar, Varshini Odayar, Nishant Gupta, Anil G. Jegga, Anil G. Jegga, Satish K. Madala, Satish K. Madala
Published 2021-03-01

Unsupervised gene expression analyses identify IPF-severity correlated signatures, associated genes and biomarkers

by Yunguan Wang, Jaswanth Yella, Jing Chen, Francis X. McCormack, Satish K. Madala, Anil G. Jegga
Published 2017-10-01

Inhibition of Aurora Kinase B attenuates fibroblast activation and pulmonary fibrosis

by Rajesh K Kasam, Sudhir Ghandikota, Divyalakshmi Soundararajan, Geereddy B Reddy, Steven K Huang, Anil G Jegga, Satish K Madala
Published 2020-09-01

Pan-transcriptome-based candidate therapeutic discovery for idiopathic pulmonary fibrosis

by Yunguan Wang, Jaswanth K. Yella, Sudhir Ghandikota, Tejaswini C. Cherukuri, Harshavardhana H. Ediga, Satish K. Madala, Anil G. Jegga
Published 2020-11-01

IL-31-Driven Skin Remodeling Involves Epidermal Cell Proliferation and Thickening That Lead to Impaired Skin-Barrier Function.

by Brijendra Singh, Anil G Jegga, Kumar S Shanmukhappa, Ramakrishna Edukulla, Gurjit H Khurana Hershey, Mario Medvedovic, Stacey R Dillon, Satish K Madala
Published 2016-01-01

Correction: IL-31-Driven Skin Remodeling Involves Epidermal Cell Proliferation and Thickening That Lead to Impaired Skin-Barrier Function.

by Brijendra Singh, Anil G Jegga, Kumar S Shanmukhappa, Ramakrishna Edukulla, Gurjit Kaur Khurana Hershey, Mario Medvedovic, Stacey R Dillon, Satish K Madala
Published 2017-01-01

Rapamycin Regulates Bleomycin-Induced Lung Damage in SP-C-Deficient Mice

by Satish K. Madala, Melissa D. Maxfield, Cynthia R. Davidson, Stephanie M. Schmidt, Daniel Garry, Machiko Ikegami, William D. Hardie, Stephan W. Glasser
Published 2011-01-01

Cardiac metabolic pathways affected in the mouse model of barth syndrome.

by Yan Huang, Corey Powers, Satish K Madala, Kenneth D Greis, Wendy D Haffey, Jeffrey A Towbin, Enkhsaikhan Purevjav, Sabzali Javadov, Arnold W Strauss, Zaza Khuchua
Published 2015-01-01

Dual targeting of MEK and PI3K pathways attenuates established and progressive pulmonary fibrosis.

by Satish K Madala, Ramakrishna Edukulla, Mukta Phatak, Stephanie Schmidt, Cynthia Davidson, Thomas H Acciani, Thomas R Korfhagen, Mario Medvedovic, Timothy D Lecras, Kimberly Wagner, William D Hardie
Published 2014-01-01